Searchable abstracts of presentations at key conferences in endocrinology

ea0063oc12.1 | Endocrine Connections 2 | ECE2019

Weekly shifts in light-dark cycle disrupt circadian clock gene expression in bone and reduce bone turnover

Schilperoort Maaike , Bravenboer Nathalie , Kroon Jan , Lim Joann , Ruyven Leo van , Rensen Patrick , Kooijman Sander , Winter Elizabeth

The past decade, epidemiological studies have associated disturbances of the biological clock, as occurs in shift work, with low bone mineral density and increased fracture risk. As a large part of the working population participates in shift work (e.g. almost 30% of workers in the U.S.), this demonstrates the need for further research on the risk of skeletal disorders associated with circadian disturbances. In this study, we aimed to investigate to what extent rhythmicity exi...

ea0041gp174 | Receptors & Signalling | ECE2016

5β-reductase (AKR1D1) is a regulator of glucose homeostasis in human hepatocytes and development of model systems to define its role in metabolic liver disease

Nikolaos Nikolaou , Dunford James , Green Charlotte , Lee Wenhwa , Lim Reina , Gathercole Laura , McKeating Jane , Oppermann Udo , Hodson Leanne , Tomlinson Jeremy

Non-alcoholic fatty liver disease is the hepatic manifestation of the global epidemic of metabolic disease. Steroid hormones, including glucocorticoids and sex steroids, regulate metabolic phenotype, and in addition, bile acids have recently been identified as potent metabolic regulators. 5β-reductase (AKR1D1) is predominantly expressed in the liver and is a crucial regulator of steroid hormone clearance as well as bile acid synthesis. Its role in pathogenesis of metaboli...

ea0059p127 | Neuroendocrinology and pituitary | SFEBES2018

Identifying disease causing variants in aryl hydrocarbon receptor-interacting protein (AIP) variants and their significance on the clinical phenotypes

Yang Zhou Jordi , Lillina Vignola M , Collier David , Thong Lim Chung , Iacovazzo Donato , Awad Sherine , Korbonits Marta

Introduction: Mutations in the aryl hydrocarbon receptor-interaction protein (AIP) gene predisposes to growth hormone or prolactin secretin adenomas, usually, manifesting before the age of 30 years old. There are 834 variants of the AIP reported in the GnomAD database and over 100 variants have been described in patients with pituitary adenomas. While the pathogenic role of variants resulting in truncated protein is beyond doubt, determination of the clinical...

ea0038p396 | Steroids | SFEBES2015

Model systems to define the role of AKR1D1 in metabolic liver disease

Nikolaou Nikolaos , Gathercole Laura , Dunford James , Lee Wenhwa , Lim Reina , McKeating Jane , Oppermann Udo , Hodson Leanne , Tomlinson Jeremy

Non-alcoholic fatty liver disease is the hepatic manifestation of the global epidemic of metabolic disease. It is tightly associated with obesity and type 2 diabetes, yet the precise mechanisms that drive its aetiology are not fully defined. Steroid hormones, including glucocorticoids and sex steroids, regulate metabolic phenotype, and in addition, bile acids have recently been identified as potent metabolic regulators. AKR1D1 (5β-reductase), is predominantly expressed in...

ea0034p361 | Steroids | SFEBES2014

Endogenous androgen-mediated modulation of neointima formation is independent of vascular androgen receptor

Wu Junxi , Hadoke Patrick , Mair Iris , Lim Win Gel , Millar Eileen , Milne Laura , Denvir Martin , Smith Lee

Aims: Low circulating testosterone levels are associated with increased cardiovascular risk and there is evidence that androgens inhibit arterial lesion formation. This investigation addressed the hypothesis that androgens directly inhibit neointimal lesion formation by stimulation of vascular androgen receptor.Methods and results: Mice were generated with selective deletion of androgen receptor from vascular (endothelial or smooth muscle) cells. Castrat...

ea0070oc2.7 | Bone and Calcium | ECE2020

Surgery alone or surgery in combination with postoperative zoledronic acid for the treatment of osteoporosis in primary hyperparathyroidism: a 2-year double-blind randomized placebo-controlled study

Ryhänen Eeva , Koski Anna-Mari , Eliisa Loyttyniemi , Ulla Kiviniemi , Schalin-Jantti Camilla , Matti Välimäki

Background: Osteoporosis is common in primary hyperparathyroidism (PHPT). It is also an indication for parathyroidectomy in PHPT. Bone mineral density (BMD) measured by dual-energy x-ray absorptiometry (DXA) increases after successful surgery. Alendronate significantly increases BMD in PHPT patients not undergoing surgery. It is not known whether surgery alone or in combination with postoperative zoledronic acid more efficiently improves bone health in PHPT.<p class="abste...

ea0070aep913 | Thyroid | ECE2020

Effect of increased levothyroxine dose on depressive mood in older adults undergoing thyroid hormone replacement therapy

Hoon Moon Jae , Won Han Ji , Jung Oh Tae , Hee Choi Sung , Lim Soo , Woong Kim Ki , Chul Jang Hak

Background: Depressive mood consequent to hypothyroidism can be reversed with levothyroxine (LT4) replacement therapy. However, it is unclear whether increasing LT4 dose confers additional mood benefits.Methods: This was a single-blind before-and-after study of 26 patients with hypothyroidism who were aged 65 years or older and undergoing LT4 replacement therapy. Geriatric Depression Scale (GDS-K) and Hyperthyroid Symptom Scale (HSS-K) were assessed at b...

ea0025p65 | Clinical biochemistry | SFEBES2011

Proton pump inhibitor (PPI) therapy in patients admitted to a diabetes and endocrine medical ward: are there clear indications?

Teo Luke , Mok Michelle , Macnair Andrew , Nunkoo Prakashmini , Lim Albert , Muttiah Siobhan , Warlow Margaret , Dipper Christian , Quinton Richard

Introduction: Proton pump inhibitors (PPIs) were until very recently perceived to be safe, effective and inexpensive. As a result they are widely prescribed empirically, beyond their core indications. However dose-dependent adverse reactions increasingly reported include diarrhoea, resistant hypomagnesaemia/hypocalcaemia and interstitial nephritis. Moreover, they are associated with increased rates of vertebral and wrist fractures, and increased C. difficile carriage rate....

ea0011p783 | Thyroid | ECE2006

Long-term results of decompression surgery in thyroid-associated ophthalmopathy

Jernfors Mia , Välimäki Matti , Pitkäranta Anne , Setälä Kirsi , Laitinen Kalevi

Graves’ ophthalmopathy is an autoimmune disorder with orbital tissue inflammation. Decompression surgery is considered when conservative treatment fails. Indications for this operation are optic neuropathy, severe inflammation with pain and proptosis.The aim of the present study is to describe the long-term results of decompression surgery in patients with thyroid-associated ophthalmopathy (TAO. This study includes retrospective analysis and clinica...

ea0056gp81 | Diabetes Complications | ECE2018

Impaired cortisol and growth hormone counterregulatory responses during severe hypoglycemia in type 2 diabetes mellitus

Rhyu Young A , Jang Ju-Young , Park Sooyoun , Kim Yoonjung , An Jee Hyun , Kim Dong-Lim , Kim Suk Kyeong , Song Kee-Ho

Background: Cortisol and growth hormone elevations are critical counterregulatory responses to severe hypoglycemia. However, the proportion and clinical characteristics of type 2 diabetic patients who fail to show appropriate cortisol and/or growth hormone secretion in response to severe hypoglycemia have not been investigated.Methods: We measured the plasma cortisol and growth hormone levels in type 2 diabetes with severe hypoglycemia (defined as blood ...